Pancreatic cancer

In 2022, 14,500 new cases were estimated in Italy. The mortality rate has not changed significantly in recent years and pancreatic cancer remains the tumor with the lowest survival both one year after diagnosis (34 percent in men and 37.4 percent in women) and five years (11 percent in men and 12 percent in women).

The University Hospital Biobank of Padova processes and stores tumor tissue samples and healthy counterparts, together with the respective blood products, according to its Operating Procedures, updated to the most recent national and international regulatory and scientific developments. The clinical data of patients related to the samples are continuously updated following the follow-up of the cases treated.